Misplaced Pages

Pharmaceutical industry

Article snapshot taken from Wikipedia with creative commons attribution-sharealike license. Give it a read and then ask your questions in the chat. We can research this topic together.

This is an old revision of this page, as edited by 67.150.120.190 (talk) at 04:51, 10 August 2005 (Controversies). The present address (URL) is a permanent link to this revision, which may differ significantly from the current revision.

Revision as of 04:51, 10 August 2005 by 67.150.120.190 (talk) (Controversies)(diff) ← Previous revision | Latest revision (diff) | Newer revision → (diff)

A pharmaceutical company (or drug company) is a company licensed to discover, develop, market and distribute drugs.

Most large pharmaceutical companies were founded in the 20th century, and derive their market share from a few well-marketed preparations. Some of the reason for this is that the process of development, clinical trials and marketing is expensive and takes a long time. After this the company will usually be granted a patent for the drug for about 20 years. Drugs are initially sold at a price higher than after competition is introduced. When the patent for the drug runs out, a generic is usually created by a competing company and released, causing the price to drop markedly.

Controversies

Recently, some large companies have received a fair share of criticism. Examples are:

  • Accusations of forging or suppressing clinical trial results to maximise uptake of some medications;
  • Accusations of manipulating the market for their products by showering doctors with free gifts, meals in fine restaurants, all-expenses-paid luxury vacations, tickets to athletic or performing arts events, and so on.
  • Too much advertising materials in the doctor's office, such as Viagra clocks, poster ads, sanitary paper ads (the paper on the table where the patients sit/lie down), etc.
  • Critics don't like the pharmaceutical companies' salesman, who try to sell new drugs to the doctor during business hours, interrupting the doctor's schedule and making patients wait longer.
  • Pharmaceutical companies donate millions to medical schools. In return, the schools teach doctors about the drugs the pharmaceutical company is selling. The medical school becomes a salesmen for the pharmaceutical companies. Pharmaceutical companies use their influence over the med schools to discourage the teaching of alternative medicines, such as herbs found in health food stores. Consequently, the doctors graduating from med school know nothing of natural alternatives, critics say.
  • Criticism for keeping the price of patented AIDS medication artificially high, limiting theraputic options for patients in the Third World, where the most people have AIDs. The patents, enforced worldwide by the World Trade Organization, bar the cheap generic manufacture of these medications, and third world countries often lack the economic resources to purchase expensive brand-name drugs from their American and European manufacturers. Pharmaceutical companies claim that lowering the price will not generate enough profits, and cannot be justified given these drugs' high development costs. Proposals to allow the manufacture generic AIDS drugs are not without controversy; it is sometimes claimed that this might cause pharmaceutical companies to move away from AIDS drug research and focus their research on other, more profitable areas. In March of 2001, South Africa was sued by 41 pharmaceutical companies for their Medicines Act, which allowed the import and generic production of cheap AIDS drugs. The case was later dropped after protest around the world. Eventually, the patents for the AIDS drugs will expire, allowing cheap generics on the market. By then, millions will die who could have been saved.

Bibliography

  • Ray Moynihan, Alan Cassels: Selling sickness: How the world's biggest pharmaceutical companies are turning us all into patients". Nation Books, New York, 2005.
  • Merrill Goozner: The $800 million pill. University of California Press, Berkeley, 2004, 297 S. ISBN 0-520-23945-8.
  • Marcia Angell: The truth about the drug companies. Random House, New York, 2004, 305 S. ISBN 0-375-50846-5.

See also

Categories: